Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

PFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...

Strong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...

Revenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...

Pfizer and BioNTech's vaccine was authorized for children under 5 years of age in June, based on data that showed the vaccine generated a s...

The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...

The study will have 1,420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech Covid vaccine or an Omic...

The Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...

India is reluctant to provide such overseas indemnity but is in talks for an early resolution to facilitate the supply of the Pfizer-BioNTe...

The Municipal Corporation of Greater Mumbai said on Tuesday that it has received eight bids for the global tender floated by it for the pro...

In a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-B...

In its response, Pfizer said that alternative dosing regimens of its vaccine had not been evaluated yet and the decision to do that resided...

"This finding can help countries make informed decisions regarding vaccine policy -- for instance, whether those previously infected should...

The panel observed that incidents of serious adverse effects such as palsy and anaphylaxis and the causality of the events with the vaccine...

“India will have to give approval if it has to secure free doses of Pfizer vaccine from the Covax facility,” an official said. “Without giv...

"Today's Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19," said Pfizer CEO Albert Bourla.

It said the updated analysis was based on 8,000 trial participants. Pfizer said in a previous analysis that 3.7 per cent of 6,000 volunteer...